Phillip M. Rappold, Ph.D.
Affiliations: | 2013 | School of Medicine and Dentistry | University of Rochester, Rochester, NY |
Area:
Neuroscience Biology, General Biology, PathologyGoogle:
"Phillip Rappold"Mean distance: 53433
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rappold PM, Cui M, Grima JC, et al. (2014) Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nature Communications. 5: 5244 |
Rappold PM, Cui M, Chesser AS, et al. (2011) Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proceedings of the National Academy of Sciences of the United States of America. 108: 20766-71 |
Lim S, Chesser AS, Grima JC, et al. (2011) D-β-hydroxybutyrate is protective in mouse models of Huntington's disease. Plos One. 6: e24620 |
Rappold PM, Tieu K. (2010) Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 413-23 |
Cui M, Aras R, Christian WV, et al. (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 106: 8043-8 |